“Prostate Cancer Today”, October 13, 2018 (in Norfolk, VA)

This is an initial announcement that Prostate Cancer International will be holding its second annual prostate cancer patient meeting (“Prostate Cancer Today: Living Well; Choosing Wisely”) on October 13, 2018, in Norfolk, Virginia, USA. … READ MORE …

Patient choice and the effectiveness and safety of HIFU

An interesting article has just been published in the Journal of Urology which helps to provide information (and context) about the quality of data supporting the use of high-intensity focused ultrasound (HIFU) in the treatment of prostate cancer. … READ MORE …

A survey on “Understanding your prostate cancer experience”

Researchers at the University of Galway in Ireland have recently posted a short, anonymous, questionnaire on line related to psychological and emotional aspects of being diagnosed with and treated for prostate cancer. It took about 7 minutes to complete. … READ MORE …

Just fix the [deleted] phone — please!

This has nothing to do with prostate cancer in particular, but a lot to do with medical practices and the patient experience, so it’s probably going to interest at least some of our readers. So click here and pass it on to your doctor’s office after you’ve read it (if appropriate).

 

Howard Wolinsky’s continuing patient journey

To quote Howard himself, “Not much on PC, but FYI.” But on the other hand, it is very much about the sometimes challenging aspects of “being a patient” — prostate cancer included. … READ MORE …

PCF’s new prostate cancer patient guide

Over the past few months new staff at the Prostate Cancer Foundation (PCF) in Santa Monica, CA, have been focused on developing new information and new content for the prostate cancer patient community that is more patient oriented than research oriented. An example is PCF’s new, 72-page Prostate Cancer Patient Guide. … READ MORE …

Patients’ understanding of the risks and benefits of first-line treatment

A newly published article in BJU International has (finally) proven something many prostate cancer educators and advocates have known for years: many patients have a very poor appreciation of the risks and benefits of their differing treatment options at the time they make decisions about first-line treatment for localized prostate cancer. … READ MORE …